Sei Investments Co. Lowers Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Sei Investments Co. lowered its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 14.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 69,675 shares of the company's stock after selling 11,762 shares during the period. Sei Investments Co. owned approximately 0.46% of U.S. Physical Therapy worth $6,181,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. CBIZ Investment Advisory Services LLC lifted its holdings in shares of U.S. Physical Therapy by 59.8% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock valued at $29,000 after buying an additional 122 shares during the period. Venturi Wealth Management LLC lifted its holdings in U.S. Physical Therapy by 3,200.0% in the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock valued at $64,000 after acquiring an additional 704 shares during the period. Pacer Advisors Inc. purchased a new stake in U.S. Physical Therapy in the 4th quarter worth approximately $113,000. Mutual of America Capital Management LLC acquired a new stake in shares of U.S. Physical Therapy during the 4th quarter worth approximately $203,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of U.S. Physical Therapy by 57.1% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company's stock valued at $223,000 after purchasing an additional 956 shares in the last quarter.

U.S. Physical Therapy Stock Down 5.4 %

Shares of NYSE:USPH traded down $3.91 on Thursday, hitting $68.62. 133,872 shares of the company's stock were exchanged, compared to its average volume of 103,550. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. U.S. Physical Therapy, Inc. has a 1-year low of $68.31 and a 1-year high of $112.52. The company has a market capitalization of $1.04 billion, a PE ratio of 73.00, a P/E/G ratio of 3.54 and a beta of 1.37. The firm's 50-day moving average is $82.21 and its 200 day moving average is $86.34.

Remove Ads

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The company had revenue of $180.45 million during the quarter, compared to analysts' expectations of $173.10 million. Sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be given a dividend of $0.45 per share. This is a positive change from U.S. Physical Therapy's previous quarterly dividend of $0.44. The ex-dividend date is Friday, March 14th. This represents a $1.80 annualized dividend and a yield of 2.62%. U.S. Physical Therapy's payout ratio is 97.83%.

Insider Activity

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the sale, the chief operating officer now directly owns 7,168 shares of the company's stock, valued at approximately $588,564.48. This trade represents a 19.44 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.70% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. StockNews.com cut shares of U.S. Physical Therapy from a "hold" rating to a "sell" rating in a report on Friday, February 28th. Bank of America upgraded U.S. Physical Therapy from a "neutral" rating to a "buy" rating and lifted their price target for the company from $100.00 to $115.00 in a research note on Monday, December 16th. William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. JMP Securities initiated coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They issued an "outperform" rating and a $113.00 price objective for the company. Finally, Citizens Jmp upgraded U.S. Physical Therapy to a "strong-buy" rating in a research report on Monday, December 16th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $109.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.